Evidence map›Paper›PMID 36742056›Full record

ArticleFrontiers in neurology2022

Advanced age is associated with increased adverse outcomes in patients undergoing middle cerebral artery stenting.

Gong Wang, Juan Liu, Shengrong He, Xi Zhang, Libai Yang, Fei Gao, Yu Guo, Rui Xu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Gong WangDepartment of Neurology, The Second Affiliated Hospital, Army Medical University, Chongqing, China.
Juan LiuDepartment of Neurology, The Second Affiliated Hospital, Army Medical University, Chongqing, China.
Shengrong HeDepartment of Field Internal Medicine, The Second Affiliated Hospital, Army Medical University, Chongqing, China.
Xi ZhangDepartment of Radiology, The Second Affiliated Hospital, Army Medical University, Chongqing, China.
Libai YangDepartment of Neurology, The Second People's Hospital of Banan District, Chongqing, China.
Fei GaoDepartment of Neurology, The Second Affiliated Hospital, Army Medical University, Chongqing, China.
Yu GuoDepartment of Neurology, The Second Affiliated Hospital, Army Medical University, Chongqing, China.
Rui XuDepartment of Neurology, The Second Affiliated Hospital, Army Medical University, Chongqing, China.
Chongqing Medical University · CNDalian Medical University · CNArmy Medical University · CNSecond Affiliated Hospital of Chongqing Medical University · CNXian Yang Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study tried to evaluate whether advanced age has an increased incidence of major complications in patients undergoing MCA stenting. Methods: A total of 348 patients who underwent MCA stenting were reviewed from a prospectively maintained database. Ninety-day ischemic stroke, intracerebral hemorrhage, and death outcomes were compared among the young (≤40 years old), middle (41-60 years old) and old (≥61 years old) groups. Univariate analysis and multivariable logistic regression analysis were used to investigate different variables associated with 90-day major adverse events. Kaplan-Meier analysis was performed to determine long-term outcomes during follow-up. Results: The incidence of 90-day ischemic stroke was 9.26% in the old group, 2.86% in the middle group, and 0% in the young group ( Conclusion: Our data indicated that MCA stenting in elderly patients is associated with a high risk of adverse events and should be cautiously considered.

Indexed as

agecomplicationsMCA stentingretrospective studyrisk factors

Identifiers

PMID36742056
PMCPMC9889558
OpenAlexW4317396486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.